Johnson & Johnson (JNJ) support and resistance · P/E 17, rev $49.37B
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
This page maps Johnson & Johnson (JNJ) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new JNJ 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the JNJ quote page for the session range and the stock page for the full model.
Not investment advice.